Literature DB >> 21227217

Intravesical chemotherapy and immunotherapy for superficial tumors Basic mechanism of action and future direction.

H Akaza1, K H Kurth, R Williams, S Hinotsu, M A Jewett, K Naito, K Okada, P F Schellhammer, R F van Velthoven, J A Witjes.   

Abstract

Entities:  

Year:  1998        PMID： 21227217     DOI： 10.1016/s1078-1439(99)00015-0

Source DB:  PubMed          Journal:  Urol Oncol        ISSN： 1078-1439            Impact factor:   3.498


× No keyword cloud information.
  6 in total

1.  The effect of intravesical mitomycin C on the recurrence of superficial (Ta-T1) bladder cancer. A Hungarian Multicenter Study.

Authors:  J Kondás; L Kiss; A Határ; A Kiss; T Lukács; P Szeldeli; F Törzsök; I Bodrogi
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

Review 2.  Epirubicin: a review of its intravesical use in superficial bladder cancer.

Authors:  S V Onrust; L R Wiseman; K L Goa
Journal:  Drugs Aging       Date:  1999-10       Impact factor: 4.271

3.  High-dose chemotherapeutics of intravesical chemotherapy rapidly induce mitochondrial dysfunction in bladder cancer-derived spheroids.

Authors:  Takahiro Yoshida; Hiroaki Okuyama; Masashi Nakayama; Hiroko Endo; Norio Nonomura; Kazuo Nishimura; Masahiro Inoue
Journal:  Cancer Sci       Date:  2014-12-08       Impact factor: 6.716

4.  Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer.

Authors:  Tomonori Kato; Kazushi Nomura; Fukuo Kondo; Masami Wakisaka; Akira Komiya
Journal:  ScientificWorldJournal       Date:  2015-05-21

5.  Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical Nephroureterectomy.

Authors:  Xingbo Long; Xiongbing Zu; Yuan Li; Wei He; Xiheng Hu; Shiyu Tong; Zhi Wang; Minfeng Chen; Lin Qi
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

Review 6.  Orthotopic neobladder after cystectomy for bladder cancer.

Authors:  Tadao Kakizoe
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2020       Impact factor: 3.493
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.